Publication dates

All regions

Anti-infective Industry, October 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, contact lens, more »


 
1-20 of about 1 300 reports for Anti-infective

Competitor Analysis: Anti-Infective Peptides

Competitor Analysis: Anti-Infective Peptides

  • $ 462
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Anti-Infective Peptides The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation ...

Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review

Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Infective drugs. It offers active pharmaceutical ingredients and other drugs in the therapeutic areas of anti infectives, cardio vascular, musculoskeletol, erectile dysfunction and gastro intestinal. The company ...

NovaBay Pharmaceuticals, Inc. (Symbol:NBY) SWOT Analysis, Strategy, Revenues and Profits

NovaBay Pharmaceuticals, Inc. (Symbol:NBY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Urology, ophthalmology, and wound care areas. Novabay's products are used in various therapeutic areas such as urology, dermatology, ophthalmology, and neutrophase. Its aganocides are synthetic anti-infectives ...

Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Financial and Strategic SWOT Analysis Review

Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And manufacturing services. Orchid's formulations products serve various therapeutic areas such as cardiovascular, anti-diabetic, central nervous system, anti-infectives, and anti-inflammatory, among others ...

Pharmascience Inc. SWOT Analysis, Strategy, Revenues and Profits

Pharmascience Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Products, consumer products, and hospital and institutional products. The company's product portfolio spans analgesics, antianginals, anti-infectives, and cholesterol reduction agents. Pharmascience ...

Sihuan Pharmaceutical Holdings Group Ltd. (460) - Financial and Strategic SWOT Analysis Review

Sihuan Pharmaceutical Holdings Group Ltd. (460) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Range of products in the therapeutic areas of cardiovascular system, nervous system, anti-infective, metabolism and oncology. Its cardio-cerebral vascular drug product portfolio includes aoliankang ...

Cyclacel Pharmaceuticals Inc. (Symbol:CYCC) SWOT Analysis, Strategy, Revenues and Profits

Cyclacel Pharmaceuticals Inc. (Symbol:CYCC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Symbol:002294) SWOT Analysis, Strategy, Revenues and Profits

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Symbol:002294) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Formulations such as tablets, capsules, and injection formulations. It also conducts research and development of new drugs in various therapeutic areas such as cardiovascular, anti-infective, anti ...

Skystar Bio-Pharmaceutical Company (Symbol:SKBI) SWOT Analysis, Strategy, Revenues and Profits

Skystar Bio-Pharmaceutical Company (Symbol:SKBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... For the treatment of patients with cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective diseases, orthopedic diseases, gastrointestinal disorders ...

About 700 reports for Anti-infective

Download Unlimited Documents from Trusted Public Sources

Hospital Industry in China

  • June 2013 Report
  • June 2013
    44 pages
  • Hospital  

  • China  

View report >

3 Companies for Anti-infective

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Icon Group

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.